Gary Meyerrose
Texas Tech University Health Sciences Center
45 Papers
238 Citations
Gary Meyerrose is an academic researcher from Texas Tech University Health Sciences Center. The author has contributed to research in topics: Scintigraphy & Aneurysm. The author has an hindex of 11, co-authored 45 publications. Previous affiliations of Gary Meyerrose include University of Texas Health Science Center at San Antonio.
Chat about Author
Papers
Heart failure and galectin 3.
Gabriela Suarez,Gary Meyerrose +1 more
TL;DR: The prognostic value of galectin-3 as an independent predictor of mortality in patients with moderate to advanced chronic HF (CHF) is reviewed.
Detection of atherosclerotic lesions and intimal macrophages using CD36-targeted nanovesicles.
Shu-Fang Nie,Jia Zhang,Raul Martinez-Zaguilan,Souad R. Sennoune,Nazir Hossen,Alice H. Lichtenstein,Jun Cao,Gary Meyerrose,Ralph Paone,Suthipong Soontrapa,Zhaoyang Fan,Shu Wang +11 more
TL;DR: This molecular target approach may facilitate the in vivo noninvasive imaging of atherosclerotic lesions in terms of intimal macrophage accumulation and distribution and disclose lesion features related to inflammation and possibly vulnerability thereby facilitate early lesion detection and targeted delivery of therapeutic compounds to intimal Macrophages.
40
Spironolactone improves diastolic function in the elderly
TL;DR: Spironolactone prevents age‐related increases in myocardial fibrosis in old normotensive rats and helps restore diastolic function in the elderly.
39
•Journal Article
Exploring the effects of ACE inhibitor tissue penetration on vascular inflammation following acute myocardial infarction
TL;DR: This investigation into the importance of ACE inhibitor tissue penetration on a common marker of vascular inflammation, suggests a potential vascular anti-inflammatory benefit with a more highly tissue penetrating ACE inhibitor following AMI.
35
Diastolic heart failure in the elderly and the potential role of aldosterone antagonists.
TL;DR: Aldosterone antagonists inhibit the deposition of collagen matrix in the myocardium, thereby targeting the basic pathophysiological mechanism of diastolic dysfunction, and appear to represent a promising therapeutic approach for this condition.
21